GOP Tax Law Locks in High Drug Prices
The law creates a new “orphan drug” loophole that will prevent Medicare from negotiating lower prices for some high-cost prescription drugs and protect drug corporations’ monopoly pricing power.
Get The FactsPrescription Drugs

Skyrocketing drug prices have forced millions of Americans, especially seniors and retirees, to choose between paying for medicine and paying for other basics like food and shelter.
Congress must take action to rein in pharmaceutical corporations and lower drug prices once and for all.
TAKE ACTIONPrescription Drug Materials
-
Medical Journal Confirms that Medicare’s Annual Cap on Out of Pocket Drug Costs is Keeping Seniors on their Medications
May 15, 2026: New research shows that the Inflation Reduction Act’s provision capping yearly prescription drug costs has helped Medicare patients afford and stay on their prescription medications. The annual out-of-pocket drug costs cap is $2 Read More >
-
KFF Health News: Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
May 15, 2026: Since his second term started, President Donald Trump has announced, negotiated, or floated a flurry of initiatives aimed at taming the excesses of the pharmaceutical industry. No surprise. About 60% of American adults are “w Read More >
-
Retirees Welcome Second Round of Lower-Priced Drugs Negotiated Under the Inflation Reduction Act
November 25, 2025: The following statement was issued by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding the Administration's announcement of lower, negotiated prices for people with Medicare: “The requiremen Read More >
-
HHS Secretary Grilled About Medicaid, CDC Firings, and Vaccines During Contentious Hearing
September 05, 2025: During a tense hearing on Thursday, members of the Senate Finance Committee pressed HHS Secretary Robert F. Kennedy Jr. about his position on a number of issues, including Medicare drug price negotiation, vaccine skepticism, recen Read More >
-
Study Debunks Pharmaceutical Industry’s Claims That Medicare Drug Price Negotiation Would Harm R&D
July 18, 2025: A new study by Bentley University debunks the pharmaceutical industry’s claims that the Medicare drug price negotiation law would harm innovation and research. Drug research and development (R&D) spending actually increased Read More >
-
Senate Votes to Harm Older Americans’ Health and Financial Security to Reward Billionaires With Massive Tax Cuts
July 01, 2025: Deep Cuts to Medicaid and SNAP Will Put Most Vulnerable Seniors at Risk The following statement was issued by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding the Senate Budget Resolution: Read More >
-
New Fact Sheet: Threats to Retirees in House Budget Package
May 30, 2025: This week, the Alliance released a new fact sheet detailing how the Republican budget, recently passed in the House of Representatives, will be harmful for seniors. The One Big Beautiful Bill Act (H.R. 1) will slash $490 billio Read More >
-
Drug Industry Quietly Funds “Patient Advocacy” Groups to Fight Medicare Drug Price Negotiations
May 23, 2025: A new investigation by Patients for Affordable Drugs (P4AD) has uncovered a troubling tactic used by the pharmaceutical industry to protect profits and keep drug prices high: secretly funding so-called “patient advocacy” group Read More >
-
Retirees Congratulate Jan Schakowsky on Exceptional Career in Congress
May 09, 2025: Rep. Jan Schakowsky (IL) announced on Monday that she will not seek another term in Congress. She has represented Illinois’ 9th congressional district since 1999. Following the announcement, the Alliance thanked her for always f Read More >
-
Alliance for Retired Americans Urges Senate to Reject Robert F. Kennedy Jr. as Secretary of Health and Human Services
January 30, 2025: Alliance for Retired Americans leader Richard Fiesta released the following statement today regarding Robert Kennedy, Jr.’s nomination for Secretary of Health and Human Services (HHS). “During his confirmation hearings, Mr. Read More >
